Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomised, Placebo-controlled Study on the Efficacy of Iberogast® (STW5) in Patients With Irritable Bowel Syndrome

NCT01940848 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01940848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01940848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomised, Placebo-controlled Study on the Efficacy of Iberogast® (STW5) in Patients With Irritable Bowel Syndrome
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
October 11, 2013
Completion date
October 25, 2017
Enrollment
243 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome